However, recent research on low-dose atropine as a potential treatment option has shown promising results, generating considerable interest. Myopia, commonly known as nearsightedness, is an eye ...

According to a secondary analysis of the 24- Month Myopia Outcome Study of Atropine in Children (MOSAIC) trial, 0.05% atropine eye drops were more effective in controlling myopia progression and ...

Low-dose 0.01% atropine eye drops safely slowed myopia progression in children with myopia and intermittent exotropia, with some compromise on accommodative amplitude. Exotropia often coexists ...

A study that focused on children aged 5 to 12 years who lived in the United States found no difference between atropine 0.01% and placebo in treating myopia progression. Atropine 0.01% was no more ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Nightly use of 0.05% atropine eye drops in kids led to a significantly lower incidence of myopia at 2 years ...

Patients with Down's syndrome respond with abnormally great mydriasis to conjunctivally instilled atropine. This finding has been attributed to a structural anomaly of the Iris. To define the ...

The short-term use of atropine eye drops to treat myopia in children did not affect long-term visual outcomes, the prospective observational ATLAS study of participants from two randomized trials ...